Korean Diabetes J.  2009 Feb;33(1):40-47. 10.4093/kdj.2009.33.1.40.

Prevalence of the Metabolic Syndrome in Type 2 Diabetic Patients

• Kim TH
• Kim DJ
• Lim S
• Jeong IK
• Son HS
• Chung CH
• Koh G
• Lee DH
• Won KC
• Park JH
• Park TS
• Ahn J
• Kim J
• Park KG
• Ko SH
• Ahn YB
• Lee I

• KMID: 2222482
• DOI: http://doi.org/10.4093/kdj.2009.33.1.40

Abstract

BACKGROUND: The aim of this study was to analyze the prevalence of metabolic syndrome in Korean type 2 diabetic patients.
METHODS
A total of 4,240 diabetic patients (male 2,033, female 2,207; mean age 58.7 +/- 11.3 years; DM duration 8.9 +/- 7.6 years) were selected from the data of endocrine clinics of 13 university hospitals in 2006. Metabolic syndrome was defined using the criteria of the American Heart Association/National Heart Lung and Blood Institute and the criteria of waist circumference from the Korean Society for the Study of Obesity.
RESULTS
The prevalence of metabolic syndrome was 77.9% (76.7% of males, 78.9% of females). The average number of the components of metabolic syndrome was 2.4 +/- 1.1. Abdominal obesity was seen in 56.8% of the patients, hypertriglyceridemia in 42.0%, low HDL cholesterol in 65.1%, and high blood pressure in 74.9%. Abdominal obesity and high blood pressure were much more prevalent among females than males, and low HDL cholesterol was much more prevalent among males than females. The prevalence of metabolic syndrome was not different according to the duration of diabetes. Metabolic syndrome was strongly related with obesity (odds ratio, 6.3) and increased age (odds ratio in the over 70 group, 3.4).
CONCLUSION
The prevalence of metabolic syndrome was 77.9% in Korean type 2 diabetic patients. Its prevalence was greater in obese patients and in those over 40 years of age.

Keyword

Diabetes mellitus; Metabolic syndrome; Obesity

MeSH Terms

Cholesterol, HDL
Diabetes Mellitus
Female
Heart
Hospitals, University
Humans
Hypertension
Hypertriglyceridemia
Lung
Male
Obesity
Obesity, Abdominal
Prevalence
Waist Circumference
Cholesterol, HDL

Figure

• 

  Fig. 1 Prevalence of the components of the metabolic syndrome. BP, blood pressure; HDLC, high density lipoprotein cholesterol; NS, not significant; TG, triglyceride.

• 

  Fig. 2 Prevalence of the metabolic syndrome according to DM duration group. NS, not significant.

Reference

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988. 37:1595–1607.

2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med. 1998. 15:539–553.

3. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001. 285:2486–2497.

4. American college of endocrinology. Consensus statement on guidelines for glycemic control. Endocr Pract. 2002. 8:suppl 1. S5–S11.

5. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet. 2005. 366:1059–1062.

6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. American Heart Association. National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005. 112:2735–2752.

7. Lee S, Park HS, Kim SM, Kwon HS, Kim DY, Kim DJ, Cho GJ, Han JH, Kim SR, Park CY, Oh SJ, Lee CB, Kim KS, Oh SW, Kim YS, Choi WH, Yoo HJ. Cut-off Points of Waist Circumference for Defining Abdominal Obesity in the Korean Population. Korean J Obes. 2006. 15:1–9.

8. Kim DJ, Park HS. Metabolic syndrome. Korean Society for the study of Obesity. Clinical Obesity. 2008. 3rd ed. Seoul: Korea Medical Book Publisher Co.;249–272.

9. Chung HW, Kim DJ, Jin HD, Choi SH, Ahn CW, Cha BS, Lee HC, Huh KB. Prevalence of Metabolic Syndrome according to the New Criteria for Obesity. J Korean Diabetes Assoc. 2002. 26:431–442.

10. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002. 287:356–359.

11. Korea Centers for Disease Control and Prevention. In-depth analyses for metabolic syndrome with data of the 3rd Korea National Health and Nutrition Examination Survey (2005). 2007. 205–238.

12. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas. 2008. 60:10–18.

13. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001. 24:683–689.

14. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third National Health and Nutrition Examination Survey (NHANES III). National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003. 52:1210–1214.

15. Moon MK, Cho YM, Jung HS, Kim KW, Park YJ, Jang HC, Shin CS, Park KS, Kim SY, Lee HK. The prevalence of metabolic syndrome and its relation with chronic complications in Korean type 2 diabetic patients. Korean J Lipid Atherosclerosis. 2003. 13:382–391.

16. Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM, Selby JV. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb. 1994. 14:1940–1945.

17. Rhee SY, Chon S, Oh S, Kim SW, Kim JW, Kim YS, Woo JT. Insulin Secretion and Insulin Resistance in Newly Diagnosed, Drug Naive Prediabetes and Type 2 Diabetes Patients With/Without Metabolic Syndrome. J Korean Diabetes Assoc. 2006. 30:196–206.